General Information of the Compound
| Compound ID |
CP0270573
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-Phenyl-3-piperidin-3-yl-1H-indole
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-Phenyl-3-piperidin-3-yl-1H-indole
2-phenyl-3-(3-piperidinyl)-1H-Indole
244086-74-6
3-(3-Piperidinyl)-2-phenyl-1H-indole
3-(Piperidin-3-yl)-2-phenyl-1H-indole
AKOS022450446
BDBM50099262
CHEMBL42557
DA-07759
SCHEMBL8525019
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H20N2
|
||||||||||||||||||
| Molecular Weight |
276.383
|
||||||||||||||||||
| Canonical SMILES |
C1CNCC(C1)c1c([nH]c2ccccc12)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H20N2/c1-2-7-14(8-3-1)19-18(15-9-6-12-20-13-15)16-10-4-5-11-17(16)21-19/h1-5,7-8,10-11,15,20-21H,6,9,12-13H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
FYHCOUIJWCQUMZ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Clinical Information about the Compound